SNDX R&D Expense Growth
Syndax Pharmaceuticals Inc · R&D Expense Growth
SNDX R&D Expense Growth
Latest reported7.09%period ending
SNDX FY R&D Growth (YoY) (0.00% → 7.09%)
Latest values, visible window
High-resolution chart · PNG
SNDX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 7.0917% | |
| 48.2206% | |
| 37.5809% | |
| 34.2795% | |
| 74.9737% | |
| 17.3071% | |
| -28.4697% | |
| 24.6987% | |
| 52.2217% | |
| 231.6054% | |
| -6.1523% | |
| 217.1758% | |
| -38.7786% | |
| -13.9149% | |
| 0% |